Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis

American Journal of Kidney Diseases

Volumn 60, Issue 1, 2012, Pages 126-132

  Fervenza, Fernando C ^a   Smith, Richard J H ^b   Sethi, Sanjeev ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

alternative pathway of complement; C3 glomerulonephritis; Crescentic glomerulonephritis; factor H mutation

Indexed keywords

ADENINE; ASPARAGINE; COMPLEMENT FACTOR H; CREATININE; GUANINE; SERINE;

ADULT; AMINO ACID SUBSTITUTION; ARTHRALGIA; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; CRESCENTIC NECROTIZING GLOMERULONEPHRITIS; DECREASED APPETITE; DNA STRUCTURE; ELECTRON MICROSCOPY; ERYTHROCYTE; EXON; FEVER; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTRON; KIDNEY BIOPSY; MALE; MESANGIUM CELL; MYALGIA; NEUTROPHIL; SEQUENCE ANALYSIS; SHORT CONSENSUS REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; VOMITING;

COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; MALE; MUTATION; NECROSIS; YOUNG ADULT;

EID: 84862610440     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.03.007     Document Type: Article

References (17)

1. Jennette JC, Olson LJ, Schwartz MM, Silva GF. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia, PA: Wolters Kluwer and LippincottWilliams &Wilkins; 2007:255-319.
2. Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9:729-740.
3. Sethi S, Fervenza FC, Zhang Y, et al. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol. 2011;6:1009-1017.
4. Sethi S, Gamez JD, Vrana JA, et al. Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int. 2009;75:952-960.
5. Smith RJH, Alexander J, Barlow PN, et al. New approaches to the treatment of dense deposit disease. J Am Soc Nephrol. 2007;18:2447-2456.
6. Servais A, Fremeaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007;44:193-199.
7. Walker PD, Ferrario F, Joh K, Bonsib SM. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol. 2007;20:605-616.
8. Leroy V, Fremeaux-Bacchi V, Peuchmaur M, et al. Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation. Pediatr Nephrol. 2011;26:419-424.
9. Abrera-Abeleda MA, Nishimura C, Smith JLH, et al.Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet. 2006;43:582-589.
10. Abrera-Abeleda MA, Nishimura C, Frees K, et al. Allelic variants of complement genes associated with dense deposit disease. J Am Soc Nephrol. 2011;22:1551-1559.
11. Zhang Y, Meyer NC, Wang K, et al. Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol. 2012;7:265-274.
12. Jokiranta TS, Hellwage J, Koistinen V, et al. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem. 2000;275:27657-27662.
13. Ferreira VP, Pangburn MK, Cortés C. Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol. 2010;47:2187-2197.
14. Lehtinen MJ, Rops AL, Isenman DE, et al. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J Biol Chem. 2009;284:15650-15658.
15. Jokiranta TS, Jaakola V-P, Lehtinen MJ, et al. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 2006;25:1784-1794.
16. Martínez-Barricarte R, Heurich M, Valdes-Cañedo F, et al. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest. 2010;120:3702-3712.
17. Sethi S, Nester CM, Smith RJH. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int. 2012;81:434-441.